Lung Cancer

Annual lung cancer screening, or LCS, detects cancer at a higher rate and at earlier stages, findings suggest.

Among patients with non-small cell lung cancer treated with resection surgery, those classified as stage I vs. stage III had higher recurrence-free survival estimates 5 years after the procedure, according to results published in CHEST.

Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy, according to results of a systematic review and meta-analysis published in Regional Anesthesia & Pain Medicine.

CT imaging of patients entering lung cancer treatment identified a high prevalence of atherosclerosis, according to data presented at the American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient course.

An AI tool appeared superior to two FDA-approved biomarkers for predicting how people with cancer will respond to immune checkpoint inhibitors.

Robotic bronchoscopy can help diagnose spots in the lungs when they are still small, catching cancer sooner and saving many more lives. The earlier you can diagnose someone with lung cancer, the more potential you have to cure them.

From 1990 to 2019, global lung cancer mortality rates related to tobacco have gone down, whereas rates related to ambient particulate matter have gone up, according to results published in eClinicalMedicine.

Clinicians may one day be able to treat immune checkpoint inhibitor-related myocarditis without disrupting cancer therapy, findings from a cellular investigation showed.

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.

Integrated care involving medication and intensive counseling showed effectiveness for smoking cessation among adults undergoing screening for lung cancer, the results of a randomized clinical trial showed.